A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
Clinical trial NCT05379634 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05379634
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-05
- Primary completion
- 2025-09-04
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.